Skip to main content
⌘K
·
Launch Terminal
Launch Terminal
Home
More
Companies
RMAX
Clinical Trials
Home
More
Companies
RMAX
Clinical Trials
RMAX (RMAX)
RE/MAX Holdings, Inc.
NYSE:RMAX
Real Estate
· Real Estate - Services
Mkt Cap
$290.35M
Float
18.11M
Shares O/S
21.32M
Inst Own
77.3%
SI
12.3%
Dilution
Mkt Cap
$290.35M
Float
18.11M
O/S
21.32M
Inst Own
77.3%
SI
12.3%
Dilution
NYSE:RMAX
MCap
$290.35M
Float
18.11M
O/S
21.32M
SI
12.3%
Inst Own
77.3%
Dilution
Overview
Overview
Financials
Financials
Dilution
Dilution
News
News
SEC Filings
SEC Filings
Clinical Trials
Trials
Open on Terminal
Learn
MCP
API
Cookie Preferences
